Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Diversified Consumer Services | Small Cap
Health Score : 5.85Shalby Ltd, a key player in the healthcare services sector, demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, driven by effective debt management and solid returns on capital and assets. Revenue and asset growth are also notable strengths. However, there are concerns regarding liquidity, efficiency, and certain aspects of growth and financial metrics. Declining cash flow ratios and earnings per share growth, coupled with less efficient asset utilization, present challenges. While the company maintains a reasonable coverage ratio for interest and dividends, there's a clear need to address operational inefficiencies and bolster short-term financial health to ensure sustainable growth and stability in the competitive healthcare market.
Health Score : 5.85Shalby Ltd, a key player in the healthcare services sector, demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, driven by effective debt management and solid returns on capital and assets. Revenue and asset growth are also notable strengths. However, there are concerns regarding liquidity, efficiency, and certain aspects of growth and financial metrics. Declining cash flow ratios and earnings per share growth, coupled with less efficient asset utilization, present challenges. While the company maintains a reasonable coverage ratio for interest and dividends, there's a clear need to address operational inefficiencies and bolster short-term financial health to ensure sustainable growth and stability in the competitive healthcare market.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
14.70
Industry Median
53.17
Small Cap Median
50.07
P/E RATIO
44.41
P/B RATIO
1.65
Industry Median
5.27
Small Cap Median
3.62
P/S RATIO
1.41
Industry Median
3.91
Small Cap Median
2.08
Others
PEG RATIO
-12.40
EV/EBITDA RATIO
10.54
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹153.65 as on Sep 1, 2026.
Growth Score : 4.80The growth ratios present a mixed picture. While revenue and asset growth rates are robust, indicating expansion and investment, the operating profit, EPS, and net income growth rates are concerning. This divergence suggests that while the company is growing its top line and asset base, profitability is lagging. There may be issues with cost management or operational efficiency.
Revenue Growth RateExcellent
Operating Profit Growth RatePoorEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 62.18 | 15.16 | 16.02 | 16.38 | 4.97 |
| Operating Profit Growth Rate | 37.08 | 13.11 | 29.71 | -24.58 | 5.93 |
| Earnings Per Share (EPS) Growth | 27.48 | 25.15 | 24.08 | -92.54 | 496.55 |
| Asset Growth Rate | 19.76 | 7.29 | 25.6 | 6.22 | 7.61 |
| Net Income Growth Rate | 28.57 | 25.93 | 23.53 | -97.62 | 1650 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Shalby Ltd | 5.85 | 44.41 | Undervalued | 143.00 | 10.45 | 35.00 |
| 2 | GPT Healthcare Ltd | 3.97 | 29.05 | Neutral | 74.00 | 5.15 | 42.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Shalby Ltd is a leading multi-specialty hospital chain in India, renowned for its orthopedic and joint replacement services. It operates a network of hospitals across multiple cities, providing comprehensive healthcare solutions including critical care, cardiac sciences, oncology, and neurology, establishing itself as a prominent player in the Indian healthcare sector, particularly for high-end surgeries.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Shalby Ltd's P/E ratio (TTM) is 14.70, compared to the industry median of 53.17 and large cap median of 50.07.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Shalby Ltd's P/B ratio is 1.65, compared to the industry median of 5.27 and large cap median of 3.62.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Shalby Ltd's P/S ratio is 1.41, compared to the industry median of 3.91 and large cap median of 2.08.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Shalby Ltd's PEG ratio is -12.40.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Shalby Ltd's EV/EBITDA ratio is 10.54.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Shalby Ltd's ROE is 3.48%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Shalby Ltd's ROA is 7.78%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Shalby Ltd's ROCE is 6%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Shalby Ltd's operating margin is 12.53%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Shalby Ltd's net margin is 3.07%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Shalby Ltd's current ratio is 1.14.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Shalby Ltd's debt-to-equity ratio is 0.20.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Shalby Ltd's interest coverage ratio is 2.56.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Shalby Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Shalby Ltd's EPS is 496.55.
(Source line: "Ratios as of 23 Oct 2026, based on last traded price of ₹153.65. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1994
Headquarters: Ahmedabad, Gujarat
Core Offerings: Joint Replacement Surgery, Orthopedics, Critical Care, Cardiac Sciences, Oncology
Stock Listing: NSE (SHALBY), BSE (540797)
Promoter: Dr. Vikram I. Shah and family
1994: Founded by Dr. Vikram I. Shah with a focus on joint replacement surgery in Ahmedabad. 2007: Expanded into its first multi-specialty hospital in Ahmedabad. 2010 onwards: Began expanding its hospital network across various Indian cities, including Surat, Indore, Jabalpur, Vapi, Mohali, and Jaipur. 2017: Successfully completed its Initial Public Offering (IPO) and listed on NSE and BSE. Present: Continues to operate a chain of multi-specialty hospitals with a strong focus on orthopedic care and medical tourism.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Healthcare Services | 100% | N/A (Company-wide EBITDA) |
Orthopedic and Joint Replacement: Shalby is globally recognized for its expertise in joint replacement surgeries, performing a significant volume of knee, hip, and shoulder replacements using advanced techniques and technologies.
Multi-specialty Care: Beyond orthopedics, the hospitals offer comprehensive medical services across various disciplines including cardiac sciences, oncology, neurology, critical care, gastroenterology, and renal sciences.
Tier 2 and Tier 3 City Focus: The company has strategically expanded its presence in Tier 2 and Tier 3 cities across India, aiming to provide high-quality tertiary care in underserved regions.
International Patient Services: Shalby caters to a significant number of international patients, particularly for orthopedic and other complex surgeries, establishing itself as a medical tourism destination.
Dr. Vikram I. Shah - Chairman & Managing Director. A visionary orthopedic surgeon, he founded Shalby Hospitals and is credited with developing innovative surgical techniques, particularly in knee replacement. He has been instrumental in the company's growth and reputation.
Shalby HealthCare International Limited (Mauritius)
Shalby Advanced Technologies Limited
Shalby Academy of Medical Sciences Limited
Shalby USPI LLP (USA)
Shalby Medical Centre Limited
Acquired SPS Hospitals in Ludhiana in 2019, expanding its footprint in Punjab. Entered into an asset purchase agreement for certain assets of Regeesis Dental Private Limited in FY22 for dental services.
The Shalby Ltd share price today is ₹153.65 on NSE (SHALBY), as of 23 Oct 2026.
As of 23 Oct 2026, Shalby Ltd share price is ₹153.65, with previous close ₹153.65. Today's range is ₹153.65 to ₹153.65. The 52-week range is ₹110.61 to ₹207.
As of today, Shalby Ltd's market cap is ₹1,605.64 crore (Small Cap).
Shalby Ltd's current P/E ratio is 14.70, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 50.
Shalby Ltd's current P/B ratio is 1.65.
Shalby Ltd's current dividend yield is N/A. Last dividend of ₹0.50 per share was declared on 30-May-2023.
Shalby Ltd's EPS (TTM) is ₹496.55.
Shalby Ltd is a leading multi-specialty hospital chain in India, renowned for its orthopedic and joint replacement services. It operates a network of hospitals across multiple cities, providing comprehensive healthcare solutions including critical care, cardiac sciences, oncology, and neurology, establishing itself as a prominent player in the Indian healthcare sector, particularly for high-end surgeries.
Shalby Ltd is promoted by Dr. Vikram I. Shah and family, holding 74.33% as of 23 Oct 2026.
Shalby Ltd is listed on NSE (SHALBY) and BSE (540797). Its next quarterly results are expected on August 2024 (for Q1 FY25).
Cash Earnings Per Share (Cash EPS)
